Citation Impact
Citing Papers
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Evolutionary History of a Specialized P450 Propane Monooxygenase
2008 StandoutNobel
Crystal Structure of a Cytochrome P450 2B6 Genetic Variant in Complex with the Inhibitor 4-(4-Chlorophenyl)imidazole at 2.0-Å Resolution
2010
Elimination of carbamazepine in a non-sterile fungal bioreactor
2012
Drug Interactions with Grapefruit Juice
1997
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Health effects of quercetin: From antioxidant to nutraceutical
2008 Standout
Investigation of the Mechanisms Underlying the Differential Effects of the K262R Mutation of P450 2B6 on Catalytic Activity
2008
Enzyme-Catalyzed Activation of Anticancer Prodrugs
2004
Studies on the inhibition of human cytochromes P450 by selenocysteine Se -conjugates
2003
The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities
2007
Identification of the Interactions between Cytochrome P450 2E1 and Cytochrome b5 by Mass Spectrometry and Site-directed Mutagenesis
2006
Cytochrome P450: taming a wild type enzyme
2011 StandoutNobel
Directed Evolution of Mammalian Cytochrome P450 2B1
2005
Evolving strategies for enzyme engineering
2005 StandoutNobel
Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol‐3‐sulfate
2003
Ebastine
1996
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin
2004
Up-regulation of transporters of the MRP family by drugs and toxins
2001
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
2009 StandoutNobel
Influence of Diet and Nutritional Status on Drug Metabolism
1996
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
Acute phase reaction and acute phase proteins
2005 Standout
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity
2005
Prediction of binding modes for ligands in the cytochromes P450 and other heme‐containing proteins
2005
Structures of Cytochrome P450 2B6 Bound to 4-Benzylpyridine and 4-(4-Nitrobenzyl)pyridine: Insight into Inhibitor Binding and Rearrangement of Active Site Side Chains
2011
A comparative analysis of binding sites between mouse CYP2C38 and CYP2C39 based on homology modeling, molecular dynamics simulation and docking studies
2009
Regulation of Cytochromes P450 During Inflammation and Infection
1997
Polyphenols: food sources and bioavailability
2004 Standout
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Potential Contribution of Cytochrome P450 2B6 to Hepatic 4-Hydroxycyclophosphamide Formation In Vitro and In Vivo
2011
Resveratrol: French Paradox Revisited
2012
Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review
2017 Standout
Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels
1997
Metabolism of Efavirenz and 8-Hydroxyefavirenz by P450 2B6 Leads to Inactivation by Two Distinct Mechanisms
2006
Pharmacokinetics and pharmacology of terbinafine and itraconazole
1998
Two-stage enzyme mediated drug release from LMWG hydrogels
2005 StandoutNobel
Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation
2010
Biological activity of piceatannol: Leaving the shadow of resveratrol
2011
Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
1997
Non‐natural Olefin Cyclopropanation Catalyzed by Diverse Cytochrome P450s and Other Hemoproteins
2014 StandoutNobel
Herb-Drug Interactions
2005 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
2005
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
2011 Standout
Bioluminescent Probes of Sulfatase Activity
2010 StandoutNobel
Biosensing with plasmonic nanosensors
2008 Standout
Engineering Cytochrome P450 Enzymes
2007
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Localized Surface Plasmon Resonance Spectroscopy and Sensing
2006 Standout
Enzyme Promiscuity: A Mechanistic and Evolutionary Perspective
2010 Standout
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
2001
Engineered Bacterial Mimics of Human Drug Metabolizing Enzyme CYP2C9
2011 StandoutNobel
Nanostructured Plasmonic Sensors
2008 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Structural and Thermodynamic Consequences of 1-(4-Chlorophenyl)imidazole Binding to Cytochrome P450 2B4,
2007
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
1999
Isotope Signatures Allow Identification of Chemically Cross-Linked Peptides by Mass Spectrometry: A Novel Method to Determine Interresidue Distances in Protein Structures through Cross-Linking
2010 StandoutNobel
An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution
2003
Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains
2006
Drug Resistance in Leishmaniasis
2006 Standout
Resonance Surface Plasmon Spectroscopy: Low Molecular Weight Substrate Binding to Cytochrome P450
2006
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
PolymorphicCYP2B6: Molecular Mechanisms and Emerging Clinical Significance
2007
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of Margit Spatzenegger being referenced
Amino Acid Residues Critical for Differential Inhibition of CYP2B4, CYP2B5, and CYP2B1 by Phenylimidazoles
2001
Metabolism of resveratrol in breast cancer cell lines: Impact of sulfotransferase 1A1 expression on cell growth inhibition
2007
A Truncation of 2B Subfamily Cytochromes P450 Yields Increased Expression Levels, Increased Solubility, and Decreased Aggregation While Retaining Function
2001
Clinical Importance of Hepatic Cytochrome P450 in Drug Metabolism
1995
Analysis of Differential Substrate Selectivities of CYP2B6 and CYP2E1 by Site-Directed Mutagenesis and Molecular Modeling
2003